Nektar Therapeutics
NKTR
NKTR
197 hedge funds and large institutions have $2.96B invested in Nektar Therapeutics in 2017 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 99 increasing their positions, 50 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
-4
Holders Change %
-1.99%
% of All Funds
4.92%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.1%
New
20
Increased
99
Reduced
50
Closed
22
Calls
$31.7M
Puts
$10.6M
Net Calls
+$21.1M
Net Calls Change
+$1.71M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$34.7M |
| 2 |
Primecap Management
Pasadena,
California
|
+$32.6M |
| 3 |
PC
PointState Capital
New York
|
+$25M |
| 4 |
O
OppenheimerFunds
New York
|
+$24.4M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$9.78M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$28.4M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$16.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$12.6M |
| 4 |
JPMorgan Chase & Co
New York
|
-$10.8M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$10.1M |
